ctrl K

Cullinan Oncology Inc. (CGEM)

NASDAQ: CGEM · Real-Time Price · USD

8.86

0.34 (3.99%)

At close: May 02, 2025, 12:46 PM

Cullinan Oncology Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	n/a	n/a	18.94M	n/a	n/a	n/a
Cost of Revenue	306K	310K	93K	53K	62K	70K	43K
Gross Profit	-306K	-310K	-93K	18.89M	-62K	-70K	-43K
Operating Income	-196.92M	-191.09M	144.65M	-67.95M	-60.34M	-22.27M	-14.59M
Interest Income	29.66M	21.63M	6.61M	477K	888K	620K	397K
Pretax Income	-167.46M	-169.22M	151.32M	-67.48M	-59.46M	-21.65M	-14.19M
Net Income	-167.38M	-153.16M	111.21M	-65.04M	-50.85M	-20.04M	-14.19M
Selling & General & Admin	53.71M	42.49M	40.19M	29.15M	17.12M	5.48M	5M
Research & Development	142.9M	148.16M	91.95M	57.75M	43.21M	16.79M	9.58M
Other Expenses	n/a	440K	57K	-8K	-11K	-4K	n/a
Operating Expenses	196.61M	191.09M	132.14M	86.9M	60.34M	22.27M	14.59M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	-196.92M	191.09M	132.14M	86.9M	60.34M	22.27M	14.59M
Income Tax Expense	117K	-14.12M	42.12M	-2.44M	-8.61M	-1.62M	397K
Shares Outstanding (Basic)	53.77M	41.51M	45.16M	44.29M	43.52M	43.52M	11.45M
Shares Outstanding (Diluted)	53.77M	41.55M	46.64M	44.29M	43.52M	43.52M	11.45M
EPS (Basic)	-3.11	-3.69	2.46	-1.47	-1.17	-0.46	-1.24
EPS (Diluted)	-3.11	-3.69	2.38	-1.47	-1.17	-0.46	-1.24
EBITDA	-167.15M	-190.34M	151.41M	-67.9M	-60.27M	-22.2M	-14.54M
EBIT	-167.46M	-190.65M	151.32M	-67.95M	-60.34M	-22.27M	-14.59M
Depreciation & Amortization	306K	310K	93K	53K	62K	70K	43K